HMGCR and metabolic dysfunction-associated steatotic liver disease: Nine of 51 patients with early stage NAFLD were undergoing treatment for hypercholesterolemia with hydroxymethyl glutaryl coenzyme A reductase (HMG CoA-reductase) inhibitors; commonly called statins.